| Particulars |
|
|
|
| Company Name
| Transgene Biotek Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
75.77 |
B.V. (₹) |
-0.90 |
| Sales(₹ Cr.) |
0.23 |
NP (₹ Cr.) |
-0.66 |
| NP Var% |
89.00 |
Div% |
0.00 |
| CPS(₹) |
-0.10 |
EPS (₹) |
-0.10 |
| Traded Value(₹ Lakhs) |
3.43 |
52 Week High |
12.00 |
| 52 Week Low |
6.00 |
Price BSE |
7.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
49.48 |
| P/C Ratio |
-94.20 |
P/E Ratio |
-80.90 |
| Price Vs.BV |
-7.78 |
|
| Latest Quarter |
| Year End |
202409 |
Sales (₹ Cr.) |
0.06 |
| NP(₹ Cr.) |
-0.07 |
NP Var % |
45.00 |
| Trailing Twelve Months |
| Year End |
202409 |
Sales |
0.20 |
| OPM |
-437.13 |
NP |
-0.27 |
| NP Var% |
91.48 |
EPS |
0.00 |
| PE |
0.00 |
|
|